Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 425 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/12/13
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 07/05/18
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 04/19/21
End: 06/08/22
Due: 06/08/23
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 06/18/07
End: 04/15/09
Due: 04/15/10
Phase: N/A
Priority: Normal
Start: 09/02/14
End: 07/31/29
Due: 07/31/30
Phase: N/A
Priority: Normal
Start: 04/17/17
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 05/20/19
End: 04/04/22
Due: 04/04/23
Phase: N/A
Priority: Normal
Start: 10/30/06
End: 04/08/14
Due: 04/08/15
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
Phase: N/A
Priority: Normal
Start: 04/30/98
End: 06/30/04
Due: 06/30/05
Phase: N/A
Priority: Normal
Start: 12/11/20
End: 04/22/25
Due: 04/22/26
Phase: N/A
Priority: Normal
Start: 07/22/25
End: 03/25/27
Due: 03/25/28
Phase: N/A
Priority: Normal
Start: 06/15/18
End: 02/04/21
Due: 02/04/22
Phase: N/A
Priority: Normal
Start: 01/02/23
End: 11/30/36
Due: 11/30/37
Phase: N/A
Priority: Normal
Start: 05/23/22
End: 03/19/24
Due: 03/19/25
Phase: N/A
Priority: Normal
Start: 02/02/15
End: 08/07/18
Due: 08/07/19
Phase: N/A
Priority: Normal
Start: 02/10/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 12/20/11
End: 12/17/19
Due: 12/17/20
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 08/31/93
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 02/28/09
Due: 02/28/10